Valuation: Sanofi

Capitalization 11TCr 12TCr 9.92TCr 8.99TCr 17TCr 10,52400Cr 19TCr 1,16000Cr 45TCr 4,81800Cr 46TCr 45TCr 17,60000Cr P/E ratio 2025 *
11.6x
P/E ratio 2026 * 11.9x
Enterprise value 11TCr 13TCr 11TCr 9.7TCr 18TCr 11,35500Cr 20TCr 1,25100Cr 49TCr 5,19800Cr 50TCr 48TCr 18,99000Cr EV / Sales 2025 *
2.52x
EV / Sales 2026 * 2.26x
Free-Float
87.31%
Yield 2025 *
4.77%
Yield 2026 * 5.02%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.00%
1 week-1.82%
Current month-0.82%
1 month-3.42%
3 months-18.28%
6 months-2.66%
Current year-7.40%
More quotes
1 week 85.61
Extreme 85.61
88.04
1 month 85.43
Extreme 85.43
94.1
Current year 85.43
Extreme 85.43
110.88
1 year 85.43
Extreme 85.43
110.88
3 years 76.45
Extreme 76.45
110.88
5 years 74.92
Extreme 74.92
110.88
10 years 62.5
Extreme 62.5
110.88
More quotes
Manager TitleAgeSince
Chief Executive Officer 57 01/09/2019
Director of Finance/CFO 63 01/04/2024
Chief Operating Officer 41 01/10/2023
Director TitleAgeSince
Director/Board Member 62 03/05/2013
Director/Board Member 71 01/05/2014
Director/Board Member 59 30/04/2019
More insiders
Name Weight AuM 1st Jan change
3.66% 139 M€ +10.76% -
More ETFs: Sanofi
Change 5d. change 1-year change 3-years change Capi.($)
-1.00%-1.82%+0.43%-7.61% 12TCr
+0.90%+6.43%-6.73%+179.65% 74TCr
+0.28%+1.34%+7.94%-7.58% 38TCr
-0.70%+0.66%+13.34%+38.37% 34TCr
-1.06%+0.56%+8.93%-12.36% 27TCr
-0.93%+0.08%+2.26%+19.86% 23TCr
-0.40%+1.89%-12.18%+11.47% 23TCr
-0.13%+3.47%-36.89%-3.45% 21TCr
-0.70%+1.68%-1.14%+25.32% 16TCr
-1.21%+5.10%-10.86%-49.41% 14TCr
Average -0.49%+1.94%-3.49%+19.43% 28.09TCr
Weighted average by Cap. -0.17%+2.68%-2.34%+50.45%
See all sector performances

Financials

2025 *2026 *
Net sales 4.53TCr 5.23TCr 4.25TCr 3.85TCr 7.11TCr 4,50600Cr 8.04TCr 50TCr 19TCr 2,06300Cr 20TCr 19TCr 7,53500Cr 4.85TCr 5.61TCr 4.55TCr 4.13TCr 7.62TCr 4,82800Cr 8.61TCr 53TCr 21TCr 2,21000Cr 21TCr 21TCr 8,07500Cr
Net income 943.16Cr 1.09TCr 884.96Cr 801.99Cr 1.48TCr 94TCr 1.67TCr 10TCr 4.02TCr 43TCr 4.09TCr 4TCr 1,57000Cr 905.69Cr 1.05TCr 849.8Cr 770.13Cr 1.42TCr 90TCr 1.61TCr 9.93TCr 3.86TCr 41TCr 3.93TCr 3.84TCr 1,50700Cr
Net Debt 835.53Cr 965.82Cr 783.97Cr 710.47Cr 1.31TCr 83TCr 1.48TCr 9.16TCr 3.57TCr 38TCr 3.63TCr 3.55TCr 1,39100Cr 368.98Cr 426.51Cr 346.21Cr 313.75Cr 579.23Cr 37TCr 655.17Cr 4.05TCr 1.57TCr 17TCr 1.6TCr 1.57TCr 61TCr
More financial data * Estimated data
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (79.8%): prescription drugs in the areas of specialty medicine (63.2% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (36.8%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (20.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2024, the group had 52 production sites worldwide. In October 2024, the consumer healthcare products business (Opella) was classified as a discontinued operation. Net sales are distributed geographically as follows: France (4.4%), Europe (17.6%), the United States (48.7%), China (6.5%) and other (22.8%).
Employees
82,878
More about the company
Date Price Change Volume
13/25/13 86.80 -1.00% 27,41,607
12/25/12 87.68 +1.12% 23,52,249
11/25/11 86.71 -1.00% 23,55,331
10/25/10 87.59 +0.14% 19,17,231
09/25/09 87.47 -1.06% 11,84,349

Real-time Euronext Paris, June 13, 2025 at 09:05 pm IST

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
86.80EUR
Average target price
114.73EUR
Spread / Average Target
+32.18%
Consensus

Quarterly revenue - Rate of surprise